Aspirin, Dipyridamole Drug Combination

Preferred Label : Aspirin, Dipyridamole Drug Combination;

MeSH definition : A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT ISCHEMIC ATTACK patients.;

MeSH synonym : Aspirin-Dipyridamole Drug Combination; Aspirin Dipyridamole Drug Combination; Combination, Aspirin-Dipyridamole Drug; Drug Combination, Aspirin-Dipyridamole;

MeSH hyponym : asasantin retard; TX 3301; asasantin; aggrenox; extended-release dipyridamole-aspirin; 3301, TX; TX-3301; Dipyridamole-Aspirin, Extended-Release; Extended Release Dipyridamole Aspirin; Retard, Asasantin;

Wikipedia link : https://en.wikipedia.org/wiki/Aggrenox;

Is substance : O;

Details

Origin ID

D000068342;

UMLS CUI

C0732279;

ATC code(s)
- combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Product containing aspirin and dipyridamole (medicinal product) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Aspirin/Dipyridamole [NCIt concept]
Pharmacological action(s)
- platelet aggregation inhibitors [MeSH Descriptor]
Record concept(s)
- TX 3301 [MeSH concept]
- aggrenox [MeSH concept]
- asasantin [MeSH concept]
- asasantin retard [MeSH concept]
- aspirin, dipyridamole drug combination [MeSH concept]
- extended-release dipyridamole-aspirin [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Aspirin/Dipyridamole [NCIt concept]
- Product containing aspirin and dipyridamole (medicinal product) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients